STOCK TITAN

GMED (GMED) Form 144: 20,000-share cashless option sale reported

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

GMED submitted a notice of proposed sale for 20,000 common shares via a cashless stock option exercise dated 02/25/2026. The filing lists shares outstanding 135,253,051 as of 02/25/2026. It also discloses prior sales by Kelly Huller: 10,000 shares on 02/12/2026 for $876,000 and 7,500 shares on 11/25/2025 for $674,619.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the GMED Form 144 disclose about the current proposed sale?

It reports a proposed sale of 20,000 common shares by cashless stock option exercise on 02/25/2026. The notice identifies the method as a Cashless Exercise and lists the transaction date and share quantity explicitly.

Who sold shares recently according to the GMED filing?

The filing shows recent sales by Kelly Huller: 10,000 shares sold on 02/12/2026 for $876,000 and 7,500 shares sold on 11/25/2025 for $674,619. These are reported prior dispositions.

How many GMED shares were outstanding as reported in the filing?

The filing lists shares outstanding 135,253,051 as of 02/25/2026. This number appears on the form and provides a company share count tied to the same date as the proposed sale.

What sale method is indicated for the 20,000 GMED shares?

The method is a Cashless Stock Option Exercise by the issuer, dated 02/25/2026. The form labels the transaction as a cashless exercise and records the issuer as the party for that specific 20,000-share entry.